These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 9952277)

  • 1. Relevance of systemic lupus erythematosus nephritis animal models to human disease.
    Foster MH
    Semin Nephrol; 1999 Jan; 19(1):12-24. PubMed ID: 9952277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis of murine lupus.
    Santiago-Raber ML; Laporte C; Reininger L; Izui S
    Autoimmun Rev; 2004 Jan; 3(1):33-9. PubMed ID: 14871647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis.
    Koh AE; Njoroge SW; Feliu M; Cook A; Selig MK; Latchman YE; Sharpe AH; Colvin RB; Paul E
    J Autoimmun; 2011 Aug; 37(1):48-57. PubMed ID: 21561736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of systemic autoimmunity in mouse models of lupus.
    Kono DH; Theofilopoulos AN
    Int Rev Immunol; 2000; 19(4-5):367-87. PubMed ID: 11016424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects.
    Rudofsky UH; Lawrence DA
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):713-21. PubMed ID: 10502536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of antibodies to DNA in systemic lupus erythematosus--a review and introduction to an international workshop on DNA antibodies held in London, May 1996.
    Isenberg DA; Ravirajan CT; Rahman A; Kalsi J
    Lupus; 1997; 6(3):290-304. PubMed ID: 9296771
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental use of murine lupus models.
    Peng SL
    Methods Mol Med; 2004; 102():227-72. PubMed ID: 15286389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine blockade for lupus model mice.
    Hasegawa H
    Front Biosci; 2008 Jan; 13():2900-8. PubMed ID: 17981762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity.
    Pollard KM; Pearson DL; Hultman P; Hildebrandt B; Kono DH
    Environ Health Perspect; 1999 Oct; 107 Suppl 5(Suppl 5):729-35. PubMed ID: 10502538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of systemic lupus erythematosus.
    Lindqvist AK; Alarcón-Riquelme ME
    Scand J Immunol; 1999 Dec; 50(6):562-71. PubMed ID: 10607304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.